Thomas F. Kirby Glioblastoma Foundation Award for Drug Development
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Overview
Focus Area: Glioblastoma drug development and therapeutic research
Geographic Scope: United States
Award Purpose: Supports research projects focused on developing new drugs and therapies to treat glioblastoma, particularly targeted therapeutic approaches.
Background
The inaugural 2018 award was presented to Dr. Gregory Riggins, M.D., Ph.D., Professor of Neurosurgery and Oncology at Johns Hopkins University School of Medicine, for his research project "Development of an improved version of the anti-parasitic agent Mebendazole to treat glioblastoma."
Glioblastoma Foundation Mission
Mission: To transform the standard of care for glioblastoma by supporting the development of new drugs and other effective therapies. The foundation recognizes that each glioblastoma is different and no single drug will work for everyone, thus supporting development of targeted therapies for glioblastoma.
Current Standard of Care
The current standard of care for glioblastoma consisting of radiation and chemotherapy is ineffective.
Contact & More Information
- Website: glioblastomafoundation.org
- Organization: Glioblastoma Foundation (501(c)(3) non-profit charitable organization)
What Glioblastoma Foundation Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 4
- Total given
- $89K
- Median grant
- $15K
- Range
- $10K–$50K
- By dollars: New York 56%, Illinois 24%, Maryland 20%. Top recipient cities: New York, NY; Baltimore, MD; Evanston, IL.
Example grants
Trustees of Columbia University in the City of New York · New York, NY
Glioblastoma research
$50K
John Hopkins University · Baltimore, MD
Glioblastoma research
$18K
Northwestern University · Evanston, IL
Glioblastoma research
$12K
Congress of Neurological Surgeons · Schaumburg, IL
Glioblastoma research
$10K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Cancer
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Neil Peart Neurosurgery Resident Research Award
Glioblastoma Foundation Inc
Amount
Varies
Deadline
Deadline not published
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
National Institutes of Health
Amount
Up to $700K
Deadline
January 11, 2027
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
September 10, 2027
AEA Community Seed Grant Program
Autoimmune Encephalitis Alliance Inc
Amount
$10,000
Deadline
Deadline not published
PhD in Pharmaceutical Sciences
UNC Eshelman School of Pharmacy Foundation
Amount
$35,000 + tuition + fees + health insurance
Deadline
Expected ~December
Based on past cycles
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,400,000 total
Deadline
November 23, 2026
Ready to apply for Thomas F. Kirby Glioblastoma Foundation Award for Drug Development?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Thomas F. Kirby Glioblastoma Foundation Award for Drug Development. Now let's win it.